Home » Our work

Latest work

Project

Immunisation for people living with non-communicable diseases

Immunisation for people living with non-communicable diseases

Immunisation against common respiratory infections is a crucial tool for reducing the burden of NCDs.

View Project

Project

Chronic respiratory diseases

Chronic respiratory diseases

Chronic respiratory diseases, which affect the airways and lungs, impede the lives of over 454 million people worldwide.

View Project

Publication

Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom

Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom

This qualitative paper from HPP and the Batten Disease Family Association explores the devastating impact of Batten disease, a rare group of inherited neurodegenerative disorders that mostly arise in childhood.

Learn More

Project

Building environmental considerations into the evaluation of health interventions

Building environmental considerations into the evaluation of health interventions

HPP worked with the Sustainable Healthcare Coalition to develop a discussion paper on building environmental consideration into the evaluation of health interventions.

View Project

Project

National calls to action for radioligand therapy

National calls to action for radioligand therapy

Radioligand therapy is a targeted treatment with huge potential to improve cancer care around the world; HPP collaborated with experts to identify key barriers to implementing radioligand therapy and co-developed recommendations to overcome these challenges.

View Project

Publication

Late diagnosis in cancer sparks outrage – so why not heart failure?

Late diagnosis in cancer sparks outrage – so why not heart failure?

Ahead of forthcoming national cardiovascular strategies, this article highlights the need to recognise the societal cost of delayed diagnosis in heart failure.

Learn More

Project

Meeting the needs of people with pulmonary arterial hypertension

Meeting the needs of people with pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare and progressive form of pulmonary hypertension that causes narrowing of the blood vessels in the lungs; if left untreated, PAH leads to heart failure, with high rates of hospitalisations and death.

View Project

Project

Committing to cholesterol management in England

Committing to cholesterol management in England

HPP supported multidisciplinary experts to produce a vision for change in cholesterol management as part of holistic cardiovascular disease prevention in England.

View Project

Project

Health system readiness for radioligand therapy

Health system readiness for radioligand therapy

HPP developed an international framework to assess health system readiness for radioligand therapy, an innovative cancer treatment.

View Project

See all Projects See all Publications